IL-34 mediates acute kidney injury and worsens subsequent chronic kidney disease

Authors

Jea-Hyun Baek, Laboratory of Molecular Autoimmune Disease
Rui Zeng, Laboratory of Molecular Autoimmune Disease
Julia Weinmann-Menke, Johannes-Gutenberg University Mainz
M.Todd Valerius, Harvard Stem Cell Institute
Yukihiro Wada, Laboratory of Molecular Autoimmune Disease
Amrenda K. Ajay, Brigham and Women’s Hospital
Marco Colonna, Washington University School of Medicine in St. Louis
Vicki R. Kelley, Laboratory of Molecular Autoimmune Disease

Journal

The Journal of Clinical Investigation

Publication Date

2015

Volume

125

Issue

8

Inclusive Pages

3198-3214

Document Type

Open Access Publication

DOI

10.1172/JCI81166

Rights and Permissions

Baek, J.-H., Zeng, R., Weinmann-Menke, J., Valerius, M. T., Wada, Y., Ajay, A. K., … Kelley, V. R. (2015). IL-34 mediates acute kidney injury and worsens subsequent chronic kidney disease. The Journal of Clinical Investigation, 125(8), 3198–3214. http://doi.org/10.1172/JCI81166

Recommended Citation

Baek, Jea-Hyun; Zeng, Rui; Weinmann-Menke, Julia; Valerius, M.Todd; Wada, Yukihiro; Ajay, Amrenda K.; Colonna, Marco; and Kelley, Vicki R., "IL-34 mediates acute kidney injury and worsens subsequent chronic kidney disease." The Journal of Clinical Investigation. 125, 8. 3198-3214. (2015).
https://digitalcommons.wustl.edu/open_access_pubs/4658